ABBVIE INC (1ABBV.MI) Stock Fundamental Analysis

Europe • Euronext Milan • BIT:1ABBV • US00287Y1091

185.2 EUR
+0.2 (+0.11%)
Last: Jan 26, 2026, 07:00 PM
Fundamental Rating

5

Taking everything into account, 1ABBV scores 5 out of 10 in our fundamental rating. 1ABBV was compared to 84 industry peers in the Biotechnology industry. While 1ABBV is still in line with the averages on profitability rating, there are concerns on its financial health. 1ABBV has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • 1ABBV had positive earnings in the past year.
  • 1ABBV had a positive operating cash flow in the past year.
  • Each year in the past 5 years 1ABBV has been profitable.
  • In the past 5 years 1ABBV always reported a positive cash flow from operatings.
1ABBV.MI Yearly Net Income VS EBIT VS OCF VS FCF1ABBV.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

  • 1ABBV has a Return On Assets of 1.75%. This is in the better half of the industry: 1ABBV outperforms 73.81% of its industry peers.
  • The Return On Invested Capital of 1ABBV (15.64%) is better than 91.67% of its industry peers.
  • 1ABBV had an Average Return On Invested Capital over the past 3 years of 13.67%. This is in line with the industry average of 11.98%.
  • The 3 year average ROIC (13.67%) for 1ABBV is below the current ROIC(15.64%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.75%
ROE N/A
ROIC 15.64%
ROA(3y)5.07%
ROA(5y)5.21%
ROE(3y)80.76%
ROE(5y)70.31%
ROIC(3y)13.67%
ROIC(5y)12.68%
1ABBV.MI Yearly ROA, ROE, ROIC1ABBV.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

1.3 Margins

  • With a decent Profit Margin value of 3.94%, 1ABBV is doing good in the industry, outperforming 76.19% of the companies in the same industry.
  • 1ABBV's Profit Margin has declined in the last couple of years.
  • 1ABBV's Operating Margin of 33.05% is amongst the best of the industry. 1ABBV outperforms 86.90% of its industry peers.
  • In the last couple of years the Operating Margin of 1ABBV has declined.
  • 1ABBV has a better Gross Margin (71.16%) than 60.71% of its industry peers.
  • In the last couple of years the Gross Margin of 1ABBV has declined.
Industry RankSector Rank
OM 33.05%
PM (TTM) 3.94%
GM 71.16%
OM growth 3Y-5.46%
OM growth 5Y-6.52%
PM growth 3Y-28.3%
PM growth 5Y-20.42%
GM growth 3Y0.39%
GM growth 5Y-1.92%
1ABBV.MI Yearly Profit, Operating, Gross Margins1ABBV.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1ABBV is creating value.
  • The number of shares outstanding for 1ABBV remains at a similar level compared to 1 year ago.
  • 1ABBV has more shares outstanding than it did 5 years ago.
  • 1ABBV has a worse debt/assets ratio than last year.
1ABBV.MI Yearly Shares Outstanding1ABBV.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
1ABBV.MI Yearly Total Debt VS Total Assets1ABBV.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

  • 1ABBV has an Altman-Z score of 2.38. This is not the best score and indicates that 1ABBV is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of 1ABBV (2.38) is better than 72.62% of its industry peers.
  • 1ABBV has a debt to FCF ratio of 3.49. This is a good value and a sign of high solvency as 1ABBV would need 3.49 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.49, 1ABBV belongs to the top of the industry, outperforming 80.95% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.49
Altman-Z 2.38
ROIC/WACC1.85
WACC8.44%
1ABBV.MI Yearly LT Debt VS Equity VS FCF1ABBV.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

2.3 Liquidity

  • 1ABBV has a Current Ratio of 0.72. This is a bad value and indicates that 1ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.72, 1ABBV is not doing good in the industry: 78.57% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.60 indicates that 1ABBV may have some problems paying its short term obligations.
  • 1ABBV has a Quick ratio of 0.60. This is in the lower half of the industry: 1ABBV underperforms 78.57% of its industry peers.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.6
1ABBV.MI Yearly Current Assets VS Current Liabilites1ABBV.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

4

3. Growth

3.1 Past

  • 1ABBV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.09%.
  • 1ABBV shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.51% yearly.
  • 1ABBV shows a small growth in Revenue. In the last year, the Revenue has grown by 7.40%.
  • Measured over the past years, 1ABBV shows a quite strong growth in Revenue. The Revenue has been growing by 11.11% on average per year.
EPS 1Y (TTM)-12.09%
EPS 3Y-7.24%
EPS 5Y2.51%
EPS Q2Q%-38%
Revenue 1Y (TTM)7.4%
Revenue growth 3Y0.08%
Revenue growth 5Y11.11%
Sales Q2Q%9.1%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.67% on average over the next years. This is quite good.
  • 1ABBV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.50% yearly.
EPS Next Y0.09%
EPS Next 2Y19.77%
EPS Next 3Y17.02%
EPS Next 5Y13.67%
Revenue Next Year8.75%
Revenue Next 2Y9.23%
Revenue Next 3Y8.83%
Revenue Next 5Y7.5%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1ABBV.MI Yearly Revenue VS Estimates1ABBV.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B
1ABBV.MI Yearly EPS VS Estimates1ABBV.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 23.12, the valuation of 1ABBV can be described as rather expensive.
  • Based on the Price/Earnings ratio, 1ABBV is valued cheaper than 80.95% of the companies in the same industry.
  • 1ABBV is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.67, which is the current average of the S&P500 Index.
  • 1ABBV is valuated correctly with a Price/Forward Earnings ratio of 15.05.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ABBV indicates a rather cheap valuation: 1ABBV is cheaper than 91.67% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of 1ABBV to the average of the S&P500 Index (27.20), we can say 1ABBV is valued slightly cheaper.
Industry RankSector Rank
PE 23.12
Fwd PE 15.05
1ABBV.MI Price Earnings VS Forward Price Earnings1ABBV.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 78.57% of the companies in the same industry are more expensive than 1ABBV, based on the Enterprise Value to EBITDA ratio.
  • 85.71% of the companies in the same industry are more expensive than 1ABBV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.62
EV/EBITDA 15.93
1ABBV.MI Per share data1ABBV.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of 1ABBV may justify a higher PE ratio.
  • 1ABBV's earnings are expected to grow with 17.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)267.63
PEG (5Y)9.21
EPS Next 2Y19.77%
EPS Next 3Y17.02%

6

5. Dividend

5.1 Amount

  • 1ABBV has a Yearly Dividend Yield of 3.14%. Purely for dividend investing, there may be better candidates out there.
  • 1ABBV's Dividend Yield is rather good when compared to the industry average which is at 0.66. 1ABBV pays more dividend than 97.62% of the companies in the same industry.
  • 1ABBV's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.14%

5.2 History

  • The dividend of 1ABBV is nicely growing with an annual growth rate of 7.72%!
Dividend Growth(5Y)7.72%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 489.69% of the earnings are spent on dividend by 1ABBV. This is not a sustainable payout ratio.
  • The dividend of 1ABBV is growing, but earnings are growing more, so the dividend growth is sustainable.
DP489.69%
EPS Next 2Y19.77%
EPS Next 3Y17.02%
1ABBV.MI Yearly Income VS Free CF VS Dividend1ABBV.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B
1ABBV.MI Dividend Payout.1ABBV.MI Dividend Payout, showing the Payout Ratio.1ABBV.MI Dividend Payout.PayoutRetained Earnings

ABBVIE INC

BIT:1ABBV (1/26/2026, 7:00:00 PM)

185.2

+0.2 (+0.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-31
Earnings (Next)02-04
Inst Owners75.04%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap327.32B
Revenue(TTM)59.64B
Net Income(TTM)2.35B
Analysts78.38
Price Target214.9 (16.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.14%
Yearly Dividend5.24
Dividend Growth(5Y)7.72%
DP489.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.85%
Min EPS beat(2)0.95%
Max EPS beat(2)2.75%
EPS beat(4)4
Avg EPS beat(4)1.21%
Min EPS beat(4)0.02%
Max EPS beat(4)2.75%
EPS beat(8)7
Avg EPS beat(8)0.95%
EPS beat(12)9
Avg EPS beat(12)0.65%
EPS beat(16)11
Avg EPS beat(16)0.49%
Revenue beat(2)1
Avg Revenue beat(2)-0.08%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)0.63%
Revenue beat(4)2
Avg Revenue beat(4)0.22%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.31%
Revenue beat(12)5
Avg Revenue beat(12)-0.17%
Revenue beat(16)5
Avg Revenue beat(16)-0.74%
PT rev (1m)0.67%
PT rev (3m)8.63%
EPS NQ rev (1m)-20.83%
EPS NQ rev (3m)-20.16%
EPS NY rev (1m)-6.7%
EPS NY rev (3m)-5.75%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)0.58%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.48%
Valuation
Industry RankSector Rank
PE 23.12
Fwd PE 15.05
P/S 6.47
P/FCF 19.62
P/OCF 18.51
P/B N/A
P/tB N/A
EV/EBITDA 15.93
EPS(TTM)8.01
EY4.33%
EPS(NY)12.3
Fwd EY6.64%
FCF(TTM)9.44
FCFY5.1%
OCF(TTM)10
OCFY5.4%
SpS28.6
BVpS-1.27
TBVpS-44.4
PEG (NY)267.63
PEG (5Y)9.21
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.75%
ROE N/A
ROCE 20.86%
ROIC 15.64%
ROICexc 16.59%
ROICexgc 572.43%
OM 33.05%
PM (TTM) 3.94%
GM 71.16%
FCFM 33%
ROA(3y)5.07%
ROA(5y)5.21%
ROE(3y)80.76%
ROE(5y)70.31%
ROIC(3y)13.67%
ROIC(5y)12.68%
ROICexc(3y)15.06%
ROICexc(5y)13.91%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)17.54%
ROCE(5y)16.27%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-1.81%
ROICexc growth 5Y-14.87%
OM growth 3Y-5.46%
OM growth 5Y-6.52%
PM growth 3Y-28.3%
PM growth 5Y-20.42%
GM growth 3Y0.39%
GM growth 5Y-1.92%
F-Score7
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.49
Debt/EBITDA 2.39
Cap/Depr 14.25%
Cap/Sales 1.97%
Interest Coverage 250
Cash Conversion 74.59%
Profit Quality 838.33%
Current Ratio 0.72
Quick Ratio 0.6
Altman-Z 2.38
F-Score7
WACC8.44%
ROIC/WACC1.85
Cap/Depr(3y)9.59%
Cap/Depr(5y)10.06%
Cap/Sales(3y)1.45%
Cap/Sales(5y)1.5%
Profit Quality(3y)361.43%
Profit Quality(5y)328.91%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.09%
EPS 3Y-7.24%
EPS 5Y2.51%
EPS Q2Q%-38%
EPS Next Y0.09%
EPS Next 2Y19.77%
EPS Next 3Y17.02%
EPS Next 5Y13.67%
Revenue 1Y (TTM)7.4%
Revenue growth 3Y0.08%
Revenue growth 5Y11.11%
Sales Q2Q%9.1%
Revenue Next Year8.75%
Revenue Next 2Y9.23%
Revenue Next 3Y8.83%
Revenue Next 5Y7.5%
EBIT growth 1Y27.38%
EBIT growth 3Y-5.38%
EBIT growth 5Y3.87%
EBIT Next Year-0.19%
EBIT Next 3Y15.91%
EBIT Next 5Y10.95%
FCF growth 1Y-20.4%
FCF growth 3Y-6.75%
FCF growth 5Y6.9%
OCF growth 1Y-18.24%
OCF growth 3Y-6.19%
OCF growth 5Y7.14%

ABBVIE INC / 1ABBV.MI FAQ

Can you provide the ChartMill fundamental rating for ABBVIE INC?

ChartMill assigns a fundamental rating of 5 / 10 to 1ABBV.MI.


What is the valuation status of ABBVIE INC (1ABBV.MI) stock?

ChartMill assigns a valuation rating of 6 / 10 to ABBVIE INC (1ABBV.MI). This can be considered as Fairly Valued.


What is the profitability of 1ABBV stock?

ABBVIE INC (1ABBV.MI) has a profitability rating of 6 / 10.


What is the valuation of ABBVIE INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ABBVIE INC (1ABBV.MI) is 23.12 and the Price/Book (PB) ratio is -146.17.


Can you provide the dividend sustainability for 1ABBV stock?

The dividend rating of ABBVIE INC (1ABBV.MI) is 6 / 10 and the dividend payout ratio is 489.69%.